Year 2011

US Panel Puts Google, Facebook, Communications Platforms On Human Rights Frontline

Recent events in the Arab region have brought the issue of access to the internet and social platforms sharply into the spotlight as governments have tried to block or limit internet access and cut millions of people from communication. A United States-hosted panel discussion in Geneva yesterday brought together representatives of Google, Facebook, and Access, a civil society group defending digital freedom.

WTO Talks On Geographical Indications Unable To Achieve Lift-Off

World Trade Organization members on Thursday combed through a composite text displaying the different views on a mandated multilateral system of notification and registration of geographical indications on wines and spirits. The composite text was developed last week as the result of several informal meetings. Countries now have clarified their inputs to the document and tried to define what next steps should be taken to refine it, but discussions were difficult, according to participants.

WHO Working Group Gives Guidelines To Fight Bad Medicines; IMPACT In Exile

After three days of intense negotiations on the role of the World Health Organization in the fight against low standard or falsified medicines, delegates provided recommendations for the UN agency. A subject of dissent was the relationship between the WHO and its taskforce against counterfeit medicines, with some countries calling for a suspension of the taskforce’s work, though in the end no consensus was found.

Public Input Sought In Review Of WIPO Technical Assistance

Public input is being sought this week for an external review of technical assistance provided by the World Intellectual Property Organization (WIPO). For years, questions have been raised over the fairness and appropriateness of the guidance and training provided to developing countries by WIPO provides, the UN agency whose aim is to promote protection of IP rights.

Group Discussion Deepens Over WHO Role In Stopping Poor Quality Medicines

The role of the World Health Organization in the safety, quality and efficacy of medical products is under scrutiny this week by member states and stakeholders. In particular, the focus is on the WHO’s role in the prevention and control of medical products of compromised quality, the organisation’s relationship with the international taskforce against counterfeit products, and the taskforce’s alleged focus on the protection of intellectual property rights rather than on public health issues. In several documents, the WHO tries to explain this fragile role.

Debate Rises Over Elevating Profile Of Genetic Resources At WIPO

Experts discussing the protection of genetic resources at the World Intellectual Property Organization this week are struggling to stay within their technical mandate as the issues carry significant political impact. Discussions today resulted in a marked-up text on objectives and principles of a possible international instrument that reveals key differences among members on the role of IP, and of WIPO, in genetic resources.